Goldman Sachs’s eHealth EHTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Buy
442,884
+191,716
+76% +$444K ﹤0.01% 5520
2025
Q4
$1.16M Buy
251,168
+82,544
+49% +$364K ﹤0.01% 5037
2025
Q3
$727K Buy
168,624
+6,211
+4% +$23.9K ﹤0.01% 5269
2025
Q2
$706K Buy
162,413
+18,150
+13% +$91.1K ﹤0.01% 4942
2025
Q1
$964K Buy
144,263
+40,096
+38% +$365K ﹤0.01% 4704
2024
Q4
$979K Buy
104,167
+82,451
+380% +$458K ﹤0.01% 4832
2024
Q3
$88.6K Sell
21,716
-420,922
-95% -$1.82M ﹤0.01% 5582
2024
Q2
$2.01M Buy
442,638
+365,581
+474% +$1.84M ﹤0.01% 3914
2024
Q1
$465K Buy
77,057
+7,649
+11% +$50.8K ﹤0.01% 4787
2023
Q4
$605K Sell
69,408
-5,466
-7% -$44.7K ﹤0.01% 4654
2023
Q3
$554K Buy
74,874
+309
+0.4% +$2.43K ﹤0.01% 4612
2023
Q2
$600K Sell
74,565
-37,737
-34% -$302K ﹤0.01% 4641
2023
Q1
$1.05M Sell
112,302
-28,380
-20% -$223K ﹤0.01% 4344
2022
Q4
$681K Sell
140,682
-7,143
-5% -$26.6K ﹤0.01% 4671
2022
Q3
$578K Buy
147,825
+118,775
+409% +$829K ﹤0.01% 4874
2022
Q2
$271K Sell
29,050
-3,412
-11% -$34.7K ﹤0.01% 5483
2022
Q1
$402K Sell
32,462
-2,774
-8% -$47.8K ﹤0.01% 5472
2021
Q4
$899K Sell
35,236
-135,096
-79% -$4.49M ﹤0.01% 4938
2021
Q3
$6.9M Buy
170,332
+100,696
+145% +$4.69M ﹤0.01% 3076
2021
Q2
$4.07M Buy
69,636
+47,817
+219% +$3.14M ﹤0.01% 3530
2021
Q1
$1.59M Sell
21,819
-17,199
-44% -$1.1M ﹤0.01% 4218
2020
Q4
$2.75M Sell
39,018
-135,118
-78% -$10.3M ﹤0.01% 3488
2020
Q3
$13.8M Buy
174,136
+116,622
+203% +$9.45M ﹤0.01% 2051
2020
Q2
$5.65M Sell
57,514
-110,629
-66% -$12.9M ﹤0.01% 2706
2020
Q1
$23.7M Sell
168,143
-117,274
-41% -$13.4M 0.01% 1391
2019
Q4
$27.4M Buy
285,417
+208,317
+270% +$16.2M 0.01% 1602
2019
Q3
$5.15M Buy
77,100
+7,107
+10% +$641K ﹤0.01% 2841
2019
Q2
$6.03M Sell
69,993
-67,992
-49% -$4.58M ﹤0.01% 2728
2019
Q1
$8.6M Buy
137,985
+95,552
+225% +$5.27M ﹤0.01% 2542
2018
Q4
$1.63M Buy
42,433
+2,825
+7% +$95K ﹤0.01% 3661
2018
Q3
$1.12M Sell
39,608
-8,995
-19% -$239K ﹤0.01% 3983
2018
Q2
$1.07M Sell
48,603
-22,167
-31% -$428K ﹤0.01% 4027
2018
Q1
$1.01M Buy
70,770
+7,058
+11% +$116K ﹤0.01% 4035
2017
Q4
$1.11M Sell
63,712
-10,787
-14% -$241K ﹤0.01% 4256
2017
Q3
$1.78M Buy
74,499
+37,691
+102% +$767K ﹤0.01% 4097
2017
Q2
$692K Sell
36,808
-5,733
-13% -$91.5K ﹤0.01% 4792
2017
Q1
$512K Sell
42,541
-7,192
-14% -$83.2K ﹤0.01% 5010
2016
Q4
$530K Buy
+49,733
New +$508K ﹤0.01% 5012
2016
Q3
Sell
-11,619
Closed -$163K 7049
2016
Q2
$163K Buy
+11,619
New +$141K ﹤0.01% 5841
2015
Q4
Sell
-31,576
Closed -$404K 7193
2015
Q3
$404K Sell
31,576
-23,066
-42% -$328K ﹤0.01% 5347
2015
Q2
$693K Buy
54,642
+4,372
+9% +$52.9K ﹤0.01% 4877
2015
Q1
$472K Buy
50,270
+32,688
+186% +$390K ﹤0.01% 5193
2014
Q4
$438K Buy
17,582
+4,063
+30% +$98.8K ﹤0.01% 5413
2014
Q3
$326K Sell
13,519
-213
-2% -$5.81K ﹤0.01% 5673
2014
Q2
$521K Buy
13,732
+8,960
+188% +$355K ﹤0.01% 5276
2014
Q1
$242K Sell
4,772
-32,325
-87% -$1.68M ﹤0.01% 5914
2013
Q4
$1.73M Sell
37,097
-7,317
-16% -$305K ﹤0.01% 4234
2013
Q3
$1.43M Sell
44,414
-4,236
-9% -$117K ﹤0.01% 4242
2013
Q2
$1.1M Buy
+48,650
New +$1.09M ﹤0.01% 4309

Other funds holding EHTH

Goldman Sachs's EHTH Position: Q1 2026 in Review

Goldman Sachs increased its eHealth (EHTH) stake by 76% in Q1 2026, buying an estimated $444K and bringing the position to 442,884 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #5520.

Goldman Sachs first reported a position in EHTH in Q2 2013 and has held it in 49 quarters since. The position peaked at $27.4M in Q4 2019. 104 funds tracked by Wall St. Rank hold EHTH as of Q1 2026.

  • Goldman Sachs held 442,884 shares of eHealth worth $571K as of Q1 2026.
  • Goldman Sachs bought 191,716 eHealth shares in Q1 2026, an estimated $444K.
  • eHealth made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5520 holding.
  • Goldman Sachs first reported a position in eHealth in Q2 2013 and has held it in 49 quarters since.
  • Goldman Sachs's eHealth position peaked at $27.4M in Q4 2019.
  • 104 funds tracked by Wall St. Rank held eHealth as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.